Teva Pharmaceuticals to pay $85M settlement in opioid case

Teva Pharmaceuticals has agreed to pay the state of Oklahoma an $85 million settlement in a opioid public nuisance case, according to the state’s attorney general.

Israeli-based Teva is the second drugmaker to settle with the state. Purdue Pharma agreed to a $270 million settlement in March. In both cases, money will be used to fund addiction treatment and research.

“Nearly all Oklahomans have been negatively impacted by this deadly crisis and we look forward to Tuesday, where we will prove our case against Johnson & Johnson and its subsidiaries,” said state Attorney General Mike Hunter said in his press release.

Hunter’s office has sued more than a dozen opioid drugmakers over the past several years, accusing them of contributing to an opioid crisis that has killed more than 47,000 overdose deaths in 2017, according to the Centers for Disease Control and Prevention.